Učitavanje...

Immune Checkpoint Inhibitor‐Associated Primary Adrenal Insufficiency: WHO VigiBase Report Analysis

BACKGROUND: Immune checkpoint inhibitors (ICIs) have transformed cancer therapy but may also trigger autoimmune adverse drug reactions (ADRs) referred to as immune‐related adverse events (irAEs). Although endocrinopathies are among the most common form of irAEs, primary adrenal insufficiency (PAI) i...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Oncologist
Glavni autori: Grouthier, Virginie, Lebrun‐Vignes, Bénédicte, Moey, Melissa, Johnson, Douglas B., Moslehi, Javid J., Salem, Joe‐Elie, Bachelot, Anne
Format: Artigo
Jezik:Inglês
Izdano: John Wiley & Sons, Inc. 2020
Teme:
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7418341/
https://ncbi.nlm.nih.gov/pubmed/32390168
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2019-0555
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!